The TSH-only problem
In most healthcare systems, thyroid screening means one thing: a TSH (thyroid-stimulating hormone) test. If your TSH falls between approximately 0.4-4.5 mIU/L, you're told your thyroid is normal. End of conversation. This approach misses an enormous amount of thyroid dysfunction[1].
TSH is not a thyroid hormone. It's a pituitary hormone — a signal from the brain asking the thyroid to produce more hormones. It's like measuring how loud someone is yelling instructions rather than measuring whether those instructions were followed. A normal TSH means the pituitary thinks things are fine. It doesn't tell you whether the thyroid is actually producing enough T4, whether T4 is being properly converted to active T3, whether the immune system is quietly destroying the thyroid, or whether metabolic stress is diverting T4 to inactive Reverse T3.
The five markers that actually matter
TSH: the starting point, not the finish line
TSH is produced by the anterior pituitary gland in a classic negative feedback loop: when thyroid hormones (T3 and T4) drop, TSH rises to stimulate the thyroid to produce more. When thyroid hormones are adequate, TSH falls. It's a useful screening tool, but its reference range is problematic.
The commonly used upper limit of 4.5 mIU/L is derived from population data that includes individuals with undiagnosed thyroid disease. When the NHANES III study excluded subjects with positive thyroid antibodies and other markers of thyroid disease, the 95th percentile of TSH in the healthy population was approximately 2.5 mIU/L[2]. This has led many endocrinologists to argue that the upper limit of "normal" should be lowered to 2.5-3.0 mIU/L[3].
Free T4: the thyroid's primary output
Thyroxine (T4) is the main hormone produced by the thyroid gland. It circulates mostly bound to proteins (thyroxine-binding globulin, albumin, and transthyretin), and only the unbound "free" fraction (approximately 0.03% of total T4) is biologically active. Free T4 is a direct measure of what the thyroid is producing[4].
T4 is sometimes called the "storage" thyroid hormone because it's relatively inactive on its own. Its primary role is to serve as a reservoir that gets converted into the active form, T3, in peripheral tissues. A normal Free T4 with elevated TSH suggests the thyroid is struggling but still keeping up. A low Free T4 confirms the thyroid is failing.
Free T3: the active hormone
Triiodothyronine (T3) is the biologically active thyroid hormone — it's what actually enters cells, binds to nuclear receptors, and drives metabolic rate, energy production, body temperature regulation, brain function, and hundreds of other processes. Approximately 80% of T3 is produced by peripheral conversion of T4 to T3 (primarily in the liver, kidneys, and skeletal muscle) via deiodinase enzymes[4].
This is where TSH-only testing falls apart. You can have a normal TSH, normal Free T4, and low Free T3 — meaning the thyroid is producing adequately but the conversion step is impaired. This pattern is common in chronic illness, caloric restriction, high cortisol states, selenium deficiency, iron deficiency, and liver dysfunction. The patient is symptomatic (fatigue, brain fog, weight gain, cold intolerance) but "normal" on standard testing.
Reverse T3: the metabolic brake
Reverse T3 (rT3) is the inactive mirror image of T3. Under normal conditions, approximately 40% of T4 is converted to active T3 and approximately 40% to inactive rT3 (the remaining 20% goes through other metabolic pathways). Reverse T3 competes with T3 for receptor binding but has no metabolic activity — it's essentially an anti-thyroid hormone[5].
When the body is under stress — chronic illness, severe caloric restriction, high cortisol, inflammatory states — it shifts the T4 conversion ratio away from T3 and toward rT3. This is an adaptive "euthyroid sick syndrome" or "non-thyroidal illness syndrome" (NTIS), designed to slow metabolism during periods of physiological stress. The problem arises when this response becomes chronic, leaving the person with persistently low T3, high rT3, and all the symptoms of hypothyroidism — despite "normal" TSH and Free T4.
TPO and thyroglobulin antibodies: the autoimmune question
Thyroid peroxidase (TPO) antibodies and thyroglobulin (TgAb) antibodies are markers of autoimmune thyroid disease. TPO antibodies are present in approximately 90% of patients with Hashimoto's thyroiditis, the most common cause of hypothyroidism in iodine-sufficient countries[6].
Critically, TPO antibodies can be elevated for years or decades before TSH becomes abnormal. Studies show that euthyroid (normal TSH) women with elevated TPO antibodies progress to overt hypothyroidism at a rate of approximately 4.3% per year if TSH is already elevated, and about 2.6% per year if TSH is still normal[7]. Without testing antibodies, this autoimmune process is invisible until enough thyroid tissue has been destroyed to affect hormone levels.
| Marker | Lab reference range | Optimal range | What it tells you |
|---|---|---|---|
| TSH | 0.4-4.5 mIU/L | 0.5-2.0 mIU/L | Pituitary demand signal |
| Free T4 | 0.8-1.8 ng/dL | 1.0-1.5 ng/dL | Thyroid production |
| Free T3 | 2.3-4.2 pg/mL | 3.0-4.0 pg/mL | Active hormone at tissues |
| Reverse T3 | 8-25 ng/dL | < 15 ng/dL | Metabolic braking |
| TPO antibodies | < 35 IU/mL | < 9 IU/mL | Autoimmune thyroid attack |
| Thyroglobulin Ab | < 4 IU/mL | < 1 IU/mL | Autoimmune thyroid attack |
Subclinical hypothyroidism: the gray zone
Subclinical hypothyroidism is defined as an elevated TSH (typically 4.5-10 mIU/L) with normal Free T4. It affects approximately 4-10% of adults, with higher prevalence in women and the elderly[8].
The clinical significance of subclinical hypothyroidism is debated, but the evidence supports treatment in several scenarios:
- TSH above 7-10 mIU/L: Higher progression rate to overt hypothyroidism and stronger association with cardiovascular risk
- Positive TPO antibodies: These patients are significantly more likely to progress to overt hypothyroidism[7]
- Symptomatic patients: Fatigue, weight gain, depression, constipation, and cognitive impairment may respond to levothyroxine even when TSH is only mildly elevated
- Younger patients: The evidence for treatment is stronger in younger adults, weaker in the elderly
- Pregnancy or planned pregnancy: Subclinical hypothyroidism in pregnancy is associated with adverse outcomes and should be treated
Hashimoto's thyroiditis: the most common cause
Hashimoto's thyroiditis is an autoimmune condition in which the immune system gradually destroys thyroid tissue. It is the most common cause of hypothyroidism in developed countries and affects women 5-8 times more frequently than men[6].
The hallmark finding is elevated TPO antibodies, sometimes accompanied by elevated thyroglobulin antibodies. The destruction is slow — thyroid function can be normal for years while antibodies are elevated, then gradually decline over time as more tissue is destroyed. This makes antibody testing critically important for early detection.
Hashimoto's is also associated with other autoimmune conditions — celiac disease, type 1 diabetes, vitiligo, pernicious anemia, and rheumatoid arthritis. If you have one autoimmune condition, screening for thyroid antibodies is warranted regardless of TSH level.
T4-to-T3 conversion: where the system often breaks down
The conversion of T4 to T3 depends on three deiodinase enzymes (D1, D2, D3), and this step is vulnerable to disruption from multiple factors[4]:
- Selenium deficiency: All three deiodinase enzymes are selenoproteins — they require selenium as a cofactor. The thyroid gland has the highest selenium concentration per gram of any tissue in the body. Without adequate selenium, T4-to-T3 conversion is impaired[9].
- Iron deficiency: Iron is a cofactor for thyroid peroxidase (TPO), the enzyme that produces thyroid hormones. Iron deficiency impairs thyroid hormone synthesis and reduces the effectiveness of levothyroxine in treated hypothyroid patients[1].
- Chronic stress / elevated cortisol: Cortisol shifts deiodinase activity from D2 (which converts T4 to active T3) toward D3 (which converts T4 to inactive Reverse T3). This is the biochemical basis of the "stressed thyroid" pattern.
- Gut dysfunction: Approximately 20% of T4-to-T3 conversion occurs in the gut. Dysbiosis, gut inflammation, and impaired intestinal health can reduce peripheral conversion[10].
- Caloric restriction: Severe or prolonged caloric restriction reduces T3 and increases Reverse T3 as a survival mechanism — the body slows metabolism to conserve energy.
- Liver dysfunction: The liver is the primary site of T4-to-T3 conversion. Non-alcoholic fatty liver disease, hepatitis, and other liver conditions impair conversion.
The selenium-thyroid connection
Selenium deserves special attention in thyroid health. The thyroid contains more selenium per gram than any other organ, and three critical thyroid enzyme families — deiodinases, glutathione peroxidases, and thioredoxin reductases — are all selenoproteins[9].
In Hashimoto's thyroiditis specifically, selenium supplementation has shown promising results. A meta-analysis of randomized controlled trials found that 200 mcg/day of selenomethionine significantly reduced TPO antibody levels over 3-12 months in Hashimoto's patients[11]. The proposed mechanism: selenium enhances glutathione peroxidase activity, which reduces oxidative damage to the thyroid gland during hormone production, thereby reducing the inflammatory stimulus that drives the autoimmune response.
Selenium supplementation above 200 mcg/day is not recommended, as excess selenium can be toxic. The best food source is Brazil nuts — two nuts per day provides approximately 100-200 mcg of selenium, depending on the soil where they were grown.
Iodine: essential but nuanced
Iodine is the raw material for thyroid hormone production — T4 contains four iodine atoms, T3 contains three. Severe iodine deficiency causes goiter and hypothyroidism, and it remains a significant public health problem globally[12].
However, iodine supplementation in the context of autoimmune thyroid disease is nuanced. Excessive iodine can actually worsen Hashimoto's thyroiditis by increasing thyroid oxidative stress and triggering further autoimmune flares. In iodine-sufficient populations (most of Europe, North America, Australia, and much of Asia), additional iodine supplementation is generally unnecessary and potentially harmful if Hashimoto's is present[12].
The recommended daily intake is 150 mcg for adults (250 mcg during pregnancy). Most people in iodine-sufficient countries get adequate amounts from iodized salt, dairy products, seafood, and eggs. Testing urinary iodine is the best way to assess status if there is concern about deficiency.
The iron-thyroid connection
Iron and thyroid function are deeply interconnected, and the symptoms overlap significantly (fatigue, hair loss, cold intolerance, brain fog). Iron is a cofactor for thyroid peroxidase — the enzyme that iodinates thyroglobulin to produce T3 and T4. Iron deficiency impairs this step, reducing thyroid hormone production even when the thyroid gland itself is structurally normal[1].
Studies have shown that iron-deficient hypothyroid patients on levothyroxine therapy respond poorly to treatment until iron stores are repleted[13]. This creates a common clinical scenario: a patient with Hashimoto's is started on levothyroxine, doesn't improve as expected, and the underlying iron deficiency is never investigated.
Practical interpretation: common thyroid patterns
| Pattern | TSH | Free T4 | Free T3 | Antibodies | Interpretation |
|---|---|---|---|---|---|
| Normal | 0.5-2.0 | Mid-range | Mid-upper | Negative | Healthy thyroid function |
| Subclinical hypo | 4.5-10 | Normal | Low-normal | Often + | Early thyroid failure |
| Overt hypo | > 10 | Low | Low | Often + | Thyroid failure |
| Conversion issue | Normal | Normal | Low | Variable | T4-to-T3 conversion impaired |
| Euthyroid Hashimoto's | Normal | Normal | Normal | Positive | Autoimmune destruction in progress |
| Sick thyroid | Normal/low | Low-normal | Low | Negative | Non-thyroidal illness (stress, caloric restriction) |